ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

New Resource Explains How Ketamine-Assisted Therapy Supports Mental Health, Published by Moment of Clarity

LONG BEACH, CA - October 21, 2025 - PRESSADVANTAGE -

Moment of Clarity has released a new educational resource titled "How Does Ketamine-Assisted Therapy Work?", available on their website. The article explores how ketamine-assisted therapy is being used to support patients living with depression, anxiety, post-traumatic stress disorder (PTSD), and other complex mental health conditions. By explaining both the science and the clinical context, the resource helps patients and families understand where ketamine-assisted therapy fits within broader treatment plans.

The article explains that ketamine, when administered in controlled medical environments, can influence brain chemistry in ways that support new neural pathways. Unlike traditional antidepressant medications, which often require weeks to take effect, ketamine has been shown in clinical studies to provide relief more quickly for some patients. A 2019 report from the American Psychiatric Association (APA) noted that ketamine, when used under medical supervision, can significantly reduce depressive symptoms in treatment-resistant patients. The U.S. Food and Drug Administration (FDA) has also approved a form of ketamine, esketamine (Spravato), for treatment-resistant depression, providing additional validation for its therapeutic use.

IOP Outpatient Mental Health Center, Long Beach, California. Moment of Clarity.

Moment of Clarity’s resource emphasizes that ketamine-assisted therapy is not a stand-alone solution but works best as part of a comprehensive care model. Sessions are most effective when paired with counseling, trauma-focused therapy, or approaches such as dialectical behavior therapy (DBT) and transcranial magnetic stimulation (TMS). This integration ensures that patients not only experience symptom relief but also develop long-term strategies to manage their underlying conditions.

The publication also addresses safety concerns. While ketamine is sometimes misused recreationally, the article clarifies that therapeutic use involves carefully measured, low doses administered in clinical settings under medical supervision. This structured process reduces risks and maximizes benefits. Reported side effects, such as mild dissociation or dizziness, are generally temporary, and patients are monitored throughout the treatment.

For patients and families in Long Beach, the availability of advanced treatments like ketamine-assisted therapy reflects progress in mental health care. Communities such as Bixby Knolls and Signal Hill, where military families and veterans reside, are highlighted as examples of populations that may particularly benefit from trauma-informed approaches. By offering education about therapies that go beyond standard talk therapy or medication, the resource provides reassurance that new options exist for those who have struggled with resistant symptoms.

The article also explains how ketamine-assisted therapy can be delivered across different levels of care. Patients who do not require hospitalization may access the treatment through outpatient or intensive outpatient programs (IOPs), where structured therapy is provided during the day and patients return home afterward. For those who require additional support, partial hospitalization programs (PHPs) offer a higher level of care without necessitating 24-hour inpatient admission. Integrating ketamine-assisted sessions into these frameworks allows patients to receive individualized, comprehensive care tailored to their needs.

Another critical theme is stigma reduction. Many people delay pursuing mental health treatment because they fear judgment or uncertainty about newer modalities. By presenting evidence-based explanations of how ketamine works and acknowledging FDA approval of related therapies, the resource helps normalize advanced approaches. This message is especially valuable in diverse communities throughout Long Beach, California, where access to culturally competent, innovative care remains essential.

In addition to ketamine-assisted therapy, the publication highlights the importance of addressing co-occurring conditions. Patients with depression often experience anxiety or PTSD, and therapies that combine medication with behavioral support provide more durable results. According to the National Institute of Mental Health (NIMH), treatment models that integrate pharmacological and psychotherapeutic interventions have been shown to improve patient outcomes compared to medication alone significantly.

By publishing the recent article on "How Ketamine Assisted Therapy Works," Moment of Clarity demonstrates its commitment to expanding access to reliable, evidence-based education. The resource clarifies how ketamine-assisted therapy functions, who may benefit, and how it can be combined with established therapies to support recovery.

For individuals in Long Beach seeking accurate information on advanced treatment options, this publication provides a balanced overview grounded in clinical research rather than promotional claims. By combining education with practical guidance, Moment of Clarity reinforces its role as a trusted provider of mental health services, offering hope to patients exploring innovative paths toward healing.

https://www.youtube.com/shorts/6TXiqZ-rMX0

###

For more information about Moment of Clarity Long Beach, contact the company here:

Moment of Clarity Long Beach
Marie Mello
(949) 844-3927
marie@momentofclarity.com
2664 Atlantic Ave, Long Beach, CA 90806

Recent Quotes

View More
Symbol Price Change (%)
AMZN  249.38
+0.97 (0.39%)
AAPL  275.03
+5.60 (2.08%)
AMD  240.77
-3.21 (-1.32%)
BAC  53.79
+0.37 (0.69%)
GOOG  291.28
+0.69 (0.24%)
META  625.71
-6.05 (-0.96%)
MSFT  508.67
+2.67 (0.53%)
NVDA  194.06
-4.99 (-2.51%)
ORCL  234.56
-6.27 (-2.60%)
TSLA  437.02
-8.21 (-1.84%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.